Corporate Tech Investors

PDL BioPharma

PDL BioPharma is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

PDL BioPharma (NASDAQ: PDLI) is a biotech company with a patented process to create humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL was founded in 1986 and is headquartered in Incline Village, Nevada. PDL engages in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/3/2014

Transaction History

Our records indicate that PDL BioPharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Dominique Monnet

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

PDL BioPharma has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Payventures | PDS Multinational Fashion

Share this article

About Our Corporate VC Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary